ABINGWORTH LLP Holdings
ABINGWORTH LLP is an investment fund managing more than 292.48M US dollars. The largest holdings include Vaxcyte, Vera Therapeutics and HilleVax. In Q3 2022 the fund bought assets of total value of 2.91M US dollars and sold assets of total value of 3.7M US dollars.
ABINGWORTH LLP portfolio value:
$292.47M
portfolio value
ABINGWORTH LLP quarter portfolio value change:
+22.14%
quarter
ABINGWORTH LLP 1 year portfolio value change:
-27.39%
1 year
ABINGWORTH LLP 3 years portfolio value change:
-34.87%
3 years
ABINGWORTH LLP 5 years portfolio value change:
-80.13%
5 years
ABINGWORTH LLP portfolio changes
| Period | Buy | Sel |
|---|---|---|
| Q2 2016 | 4768000 | 533000 |
| Q3 2016 | 4214000 | 7394000 |
| Q4 2016 | 51679000 | 19393000 |
| Q1 2017 | 6981000 | 7186000 |
| Q3 2017 | 5509000 | 5986000 |
| Q1 2018 | 2976000 | 33408000 |
| Q2 2018 | 28941000 | 13509000 |
| Q3 2018 | 11274000 | 4192000 |
| Q4 2018 | 7984000 | 24708000 |
| Q1 2019 | -4583000 | 11972000 |
| Q2 2019 | 147948000 | 10310000 |
| Q3 2019 | 15750000 | 31036000 |
| Q4 2019 | 57381000 | 5874000 |
| Q2 2020 | 141612000 | 3966000 |
| Q3 2020 | 28347000 | 6699000 |
| Q4 2020 | 43074000 | 113694000 |
| Q3 2021 | 124391000 | 7060000 |
| Q2 2022 | 47353000 | 3804000 |
| Q3 2022 | 2913000 | 3695000 |
ABINGWORTH LLP 13F holdings
| Stock |
|---|
| Portfolio share: 34.21% Portfolio value: 100.04M Avg. open price: N/A Current price: $44.33 P/L: N/A N/A Q2 2020 |
| Portfolio share: 21.57% Portfolio value: 63.08M Avg. open price: N/A Current price: $16.19 P/L: N/A N/A Q2 2021 |
| Portfolio share: 10.74% Portfolio value: 31.40M Avg. open price: N/A Current price: $17.5 P/L: N/A N/A Q2 2022 |
| Portfolio share: 10.26% Portfolio value: 30.01M Avg. open price: $7.84 Current price: $20.2 P/L: +157.65% Bought +30.95% shares Q4 2021 |
| Portfolio share: 8.58% Portfolio value: 25.09M Avg. open price: $4.68 Current price: $13.57 P/L: +189.96% Bought 0.00% shares Q2 2022 |
| Portfolio share: 5.44% Portfolio value: 15.90M Avg. open price: $19.46 Current price: $11.07 P/L: -43.11% Bought +19.28% shares Q1 2022 |
| Portfolio share: 2.38% Portfolio value: 6.94M Avg. open price: $9.33 Current price: $2.02 P/L: -78.35% Bought +5.69% shares Q3 2021 |
| Portfolio share: 1.52% Portfolio value: 4.44M Avg. open price: N/A Current price: $0.58 P/L: N/A N/A Q3 2021 |
| Portfolio share: 1.16% Portfolio value: 3.4M Avg. open price: N/A Current price: $0.87 P/L: N/A N/A Q3 2020 |
| Portfolio share: 0.93% Portfolio value: 2.73M Avg. open price: N/A Current price: $0.43 P/L: N/A N/A Q3 2021 |
| Portfolio share: 0.91% Portfolio value: 2.67M Avg. open price: N/A Current price: $2.04 P/L: N/A Sold -19.94% shares Q3 2017 |
| Portfolio share: 0.85% Portfolio value: 2.47M Avg. open price: N/A Current price: $1.17 P/L: N/A N/A Q3 2022 |
| Portfolio share: 0.69% Portfolio value: 2.00M Avg. open price: $1.12 Current price: $0.97 P/L: -13.63% N/A Q3 2022 |
| Portfolio share: 0.37% Portfolio value: 1.07M Avg. open price: $10.9 Current price: $0.27 P/L: -97.49% Sold -28.78% shares Q2 2022 |
| Portfolio share: 0.16% Portfolio value: 457K Avg. open price: N/A Current price: $4.17 P/L: N/A Sold -52.07% shares Q4 2018 |
| Portfolio share: 0.15% Portfolio value: 439K Avg. open price: $2.38 Current price: $1.06 P/L: -55.51% N/A Q3 2022 |
| Portfolio share: 0.05% Portfolio value: 150K Avg. open price: N/A Current price: $0.5 P/L: N/A N/A Q4 2019 |
| Portfolio share: 0.04% Portfolio value: 127K Avg. open price: N/A Current price: $0.47 P/L: N/A N/A Q1 2019 |
| Portfolio share: 0.00% Portfolio value: 13K Avg. open price: N/A Current price: $0.18 P/L: N/A Sold -80.00% shares Q1 2019 |
| Portfolio share: 0.00% Portfolio value: 0 Avg. open price: $1.12 Current price: $0.97 P/L: -13.63% Sold -100.00% shares Q3 2022 |
| Portfolio share: 0.00% Portfolio value: 0 Avg. open price: $16.65 Current price: $54.99 P/L: +230.23% Sold -100.00% shares Q3 2022 |
| Portfolio share: 0.00% Portfolio value: 0 Avg. open price: $2.38 Current price: $1.06 P/L: -55.51% Sold -100.00% shares Q3 2022 |
| Portfolio share: 0.00% Portfolio value: 0 Avg. open price: N/A Current price: $1.17 P/L: N/A Sold -100.00% shares Q3 2022 |
| Portfolio share: 0.00% Portfolio value: 0 Avg. open price: N/A Current price: N/A P/L: N/A Sold -100.00% shares Q3 2022 |
Showing TOP 24 ABINGWORTH LLP's 13F holdings.
Frequently Asked Questions (FAQ)
What is the biggest position of ABINGWORTH LLP?
The biggest position of the ABINGWORTH LLP is Vaxcyte, Inc. (PCVX) with 34.21% portfolio share worth of 100.05M US dollars.
Top 5 ABINGWORTH LLP's holdings represent 85.35% of the portfolio:
- Vaxcyte, Inc. (PCVX) – 34.21%
- Vera Therapeutics, Inc. (VERA) – 21.57%
- HilleVax, Inc. (HLVX) – 10.74%
- Adicet Bio, Inc. (ACET) – 10.26%
- Verona Pharma plc (VRNA) – 8.58%
Who is the portfolio manager of ABINGWORTH LLP?
The portfolio manager of the ABINGWORTH LLP is .
What is the total asset value of the ABINGWORTH LLP portfolio?
ABINGWORTH LLP total asset value (portfolio value) is 292.48M US dollars.
Who is ?
is the portfolio manager of the ABINGWORTH LLP.
What is (ABINGWORTH LLP) fund performance?
ABINGWORTH LLP's quarterly performance is +22.14%, annualy -27.39%. In the past 3 years, the value of 's portfolio has decreased by -35%. In the past 5 years, the value of the portfolio has decreased by -80%.
What is the ABINGWORTH LLP CIK?
ABINGWORTH LLP's Central Index Key is 0001397144 .